ERIN KOLCHARNO: Open Payments
NPI 1518651280 · STORRS, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 35 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $173 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $168 |
| Tandem Diabetes Care, Inc. | 2 | $166 |
| Abbott Laboratories | 3 | $152 |
| Sequel Med Tech, LLC | 2 | $86 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Medtronic, Inc. | 1 | $32 |
| Insulet Corporation | 1 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
| Almatica Pharma LLC | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3, Ozempic, TWIIST, GVOKE HYPOPEN, MINIMED 780G, Omnipod, TZIELD.
Industry payments across CT — which companies pay providers there.
